title: Prescription drug monitoring programs and buprenorphine maintenance: clinical considerations.
authors.affiliation: Yale University School of Medicine, West Haven, CT.
authors.forename: Michael
authors.initials: M
authors.lastname: Hoefer
authors.forename: Ismene
authors.initials: I
authors.lastname: Petrakis
mesh_terms: D000328:Adult; D002047:Buprenorphine / Q000627:therapeutic use*; D000069479:Buprenorphine, Naloxone Drug Combination; D061891:Controlled Substances; D016208:Databases, Factual / Q000331:legislation & jurisprudence; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D006078:Government Programs / Q000331:legislation & jurisprudence; D006801:Humans; D008297:Male; D009270:Naloxone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D064226:Prescription Drug Diversion; D063487:Prescription Drug Misuse; D012008:Recurrence
chemical_list: D000069479:Buprenorphine, Naloxone Drug Combination; D061891:Controlled Substances; D009292:Narcotic Antagonists; D009270:Naloxone; D002047:Buprenorphine